https://polyactiva.com/polyactiva-successfully-completes-initial-clinical-trial/ 2022-03-16T10:58:14+00:00 https://polyactiva.com/polyactiva-appoints-tracy-valorie/ 2022-03-16T10:58:44+00:00 https://polyactiva.com/polyactiva-completes-recruitment-in-key-phase-i/ 2022-03-16T10:58:55+00:00 https://polyactiva.com/polyactiva-commences-its-first-phase/ 2022-03-16T10:59:02+00:00 https://polyactiva.com/polyactiva-raises-aud9-2m/ 2022-03-16T10:59:09+00:00 https://polyactiva.com/positive-phase-iia-results/ 2022-03-17T00:31:04+00:00 https://polyactiva.com/polyactiva-presents-positive-clinical-trial-results/ 2022-03-17T00:36:36+00:00 https://polyactiva.com/polyactiva-reports-promising-phase-2a-clinical-trial-results/ 2023-11-02T03:57:09+00:00 https://polyactiva.com/polyactiva-awarded-1-5m-cureator-grant/ 2024-05-07T06:27:00+00:00 https://polyactiva.com/polyactiva-showcases-repeat-dose-clinical-data-out-to-48-weeks/ 2024-10-30T04:33:03+00:00 https://polyactiva.com/polyactiva-secures-aud-40m-in-series-c-funding/ 2025-06-18T08:02:37+00:00 https://polyactiva.com/jerry-st-peter-appointed-as-new-polyactiva-ceo-and-board-director/ 2025-06-19T06:32:13+00:00 https://polyactiva.com/polyactiva-expands-executive-team-to-drive-transformational-growth-and-advance-late-stage-clinical-development-in-the-us/ 2025-07-17T03:11:24+00:00 https://polyactiva.com/first-patient-enrolled-in-polyactivas-phase-2b-clinical-trial/ 2025-08-07T03:11:45+00:00 https://polyactiva.com/polyactiva-presents-advancements-in-next-generation-ocular-micro-implant-technology-at-eyecelerator-aao-2025/ 2025-10-22T03:52:29+00:00 https://polyactiva.com/polyactiva-and-raresight-form-strategic-collaboration-to-develop-breakthrough-treatments-for-rare-pediatric-retinal-diseases/ 2025-11-05T23:59:03+00:00